[SGMO] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
09-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 1.10%
YoY- 34.86%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 57,763 21,958 23,562 11,812 2,823 8,569 12,417 29.17%
PBT -1,271 -27,361 -12,843 -12,354 -18,968 -12,584 -7,545 -25.66%
Tax 237 -54 0 0 -3 -3,339 -209 -
NP -1,550 -27,307 -12,843 -12,354 -18,965 -9,245 -7,545 -23.16%
Tax Rate - - - - - - - -
Total Cost 59,313 49,265 36,405 24,166 21,788 17,814 19,962 19.88%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -2.68 -124.36 -54.51 -104.59 -671.80 -107.89 -60.76 -40.53%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.01 -0.24 -0.13 -0.15 -0.27 -0.13 -0.11 -32.92%
EPS Diluted -0.01 -0.24 -0.13 -0.15 -0.27 -0.13 -0.11 -32.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.